Table 4.
Antibody | Control (Not reduced), % Monomer | Reduced, % Monomer | Reduced, % New Species | Reduced, % Fragment |
---|---|---|---|---|
BisAb-A | 89 | 59 | 11 | 30 |
BisAb-B | 90 | 51 | 13 | 36 |
BisAb-C | 94 | 42 | 11 | 47 |
BisAb-D | 81 | 34 | 20 | 46 |
parental mAb | 85 | 19 | 0 | 81 |
Antibody | Control (Not reduced), % Monomer | Reduced, % Monomer | Reduced, % New Species | Reduced, % Fragment |
---|---|---|---|---|
BisAb-A | 89 | 59 | 11 | 30 |
BisAb-B | 90 | 51 | 13 | 36 |
BisAb-C | 94 | 42 | 11 | 47 |
BisAb-D | 81 | 34 | 20 | 46 |
parental mAb | 85 | 19 | 0 | 81 |